In contrast, FMTRYGB recipients revealed strong morphological and functional signatures of improved intestinal health and barrier function compared to HF-DIO (Supplementary Figure S8), which is consistent with previously reported effects of intestinal FXR activation [40, 42]. Here, NR1H4 is linked to hydrops fetalis.